Sermonix Pharmaceuticals LLC-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Sermonix Pharmaceuticals LLC - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8013388
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月28日
◆ページ数:24
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Sermonix Pharmaceuticals LLC (Sermonix) is a biotechnology company develops female-specific oncology products. The company’s lead product include lasofoxifene, which is a selective estrogen receptor modulator. Its lasofoxifene is used in the treatment of common disorders affecting women that include various osteoporosis concerns. It also offers development of SERMs for breast health, treating vulvovaginal atrophy and for both the treatment and prevention of postmenopausal osteoporosis. The company offers oncology products through proof of concept, pre-clinical, and clinical development programs. Sermonix is headquartered in Columbus, Ohio, the US.

Sermonix Pharmaceuticals LLC – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Sermonix Pharmaceuticals LLC, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Sermonix Pharmaceuticals LLC, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Sermonix Pharmaceuticals LLC, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Sermonix Pharmaceuticals LLC, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Sermonix Pharmaceuticals LLC, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Sermonix Pharmaceuticals LLC, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
Sermonix Pharma Raises Funds through Seed Financing 10
Sermonix Pharma Raises USD1.5 Million in Financing Round 11
Sermonix Pharma Raises USD1 Million in Venture Financing 12
Licensing Agreements 13
Sermonix Pharma Enters into Licensing Agreement with Duke University 13
Sermonix Pharma Expands Licensing Agreement with Ligand Pharma for Lasofoxifene 14
Sermonix Pharmaceuticals LLC – Key Competitors 15
Sermonix Pharmaceuticals LLC – Key Employees 16
Sermonix Pharmaceuticals LLC – Locations And Subsidiaries 17
Head Office 17
Recent Developments 18
Product News 18
11/28/2016: Sermonix Pharmaceuticals to Present Poster on Physician Perceptions of Menopausal SERMs at San Antonio Breast Cancer Symposium 18
08/03/2016: Sermonix Pharmaceuticals Convenes Breast Cancer Oncology Steering Committee to Explore Utility of Lasofoxifene 19
05/03/2016: Sermonix Pharmaceuticals Announces Dr. Anthony H. Wild as Board Chairman and Investor 21
03/31/2016: ermonix Pharmaceuticals to Give Lasofoxifene Oral Presentation at World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Disease 22
02/10/2016: Sermonix Pharmaceuticals to Give Two Lasofoxifene Presentations at International Society for the Study of Women’s Sexual Health Meeting 23
Appendix 24
Methodology 24
About GlobalData 24
Contact Us 24
Disclaimer 24

List of Tables
Sermonix Pharmaceuticals LLC, Pharmaceuticals & Healthcare, Key Facts 2
Sermonix Pharmaceuticals LLC, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Sermonix Pharmaceuticals LLC, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Sermonix Pharmaceuticals LLC, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Sermonix Pharmaceuticals LLC, Deals By Therapy Area, 2011 to YTD 2017 8
Sermonix Pharmaceuticals LLC, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Sermonix Pharma Raises Funds through Seed Financing 10
Sermonix Pharma Raises USD1.5 Million in Financing Round 11
Sermonix Pharma Raises USD1 Million in Venture Financing 12
Sermonix Pharma Enters into Licensing Agreement with Duke University 13
Sermonix Pharma Expands Licensing Agreement with Ligand Pharma for Lasofoxifene 14
Sermonix Pharmaceuticals LLC, Key Competitors 15
Sermonix Pharmaceuticals LLC, Key Employees 16

★海外企業調査レポート[Sermonix Pharmaceuticals LLC-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • XTL Biopharmaceuticals Ltd (XTLB):企業の財務・戦略的SWOT分析
    Summary XTL Biopharmaceuticals Ltd (XTL) is a drug development company that focuses on the acquisition and development of late-stage pharmaceutical product candidates for the treatment of unmet clinical needs. The company’s pipeline products include hCDR1 peptide and recombinant human erythropoietin …
  • MannKind Corp (MNKD)-医療機器分野:企業M&A・提携分析
    Summary MannKind Corp (MannKind) is a biopharmaceutical company that discovers, develops and commercializes therapeutic products to treat diseases such as diabetes. The company’s lead product, Afrezza is a rapid-acting, inhaled insulin used to control high blood sugar in adults with type 1 and type …
  • Petrochemical Industries Co:企業の戦略的SWOT分析
    Petrochemical Industries Co - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major product …
  • Singapore Press Holdings Limited:企業の戦略・SWOT・財務情報
    Singapore Press Holdings Limited - Strategy, SWOT and Corporate Finance Report Summary Singapore Press Holdings Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • Daimler AG (DAI):企業の財務・戦略的SWOT分析
    Daimler AG (DAI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Bank Sinopac:企業の戦略・SWOT・財務分析
    Bank Sinopac - Strategy, SWOT and Corporate Finance Report Summary Bank Sinopac - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Navy Exchange Service Command:企業の戦略・SWOT・財務情報
    Navy Exchange Service Command - Strategy, SWOT and Corporate Finance Report Summary Navy Exchange Service Command - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Lantheus Medical Imaging Inc:企業の製品パイプライン分析2018
    Summary Lantheus Medical Imaging Inc (Lantheus Medical), a subsidiary of Lantheus Holdings, Inc., develops, manufactures, and commercializes diagnostic imaging agents and products for the diagnosis of conditions that affect heart, brain, lungs and other organs using echocardiography and nuclear imag …
  • Henry Lamotte Group:企業の戦略・SWOT・財務情報
    Henry Lamotte Group - Strategy, SWOT and Corporate Finance Report Summary Henry Lamotte Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Zeltiq Aesthetics Inc:医療機器:M&Aディール及び事業提携情報
    Summary Zeltiq Aesthetics Inc (Zeltiq), formerly Juniper Medical Inc, a subsidiary of Allergan Plc, is a medical technology company that develops and commercializes non-invasive products for the reduction of fat, selectively. The company offers CoolSculpting system, which uses proprietary controlled …
  • Pharnext SA (ALPHA):企業の財務・戦略的SWOT分析
    Summary Pharnext SA (Pharnext), formerly Pharnext SAS is a biopharmaceutical company that develops novel therapies for severe neurodegenerative diseases. The company offers pleotherapy, a proprietary research and development platform based on network pharmacology that uses wide genomic data to ident …
  • Brick Brewing Co. Limited:企業の戦略・SWOT・財務分析
    Brick Brewing Co. Limited - Strategy, SWOT and Corporate Finance Report Summary Brick Brewing Co. Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Vectren Corporation (VVC)-エネルギー分野:企業M&A・提携分析
    Summary Vectren Corporation (Vectren) is an energy holding company, which carries out the distribution and transmission of natural gas and electricity. Under its wholly owned subsidiary, Vectren Utility Holdings, Inc., the company operates three utilities; Vectren Energy Delivery of Indiana - North …
  • TIVIT Terceirizacao de Tecnologia e Servicos SA:企業の戦略的SWOT分析
    TIVIT Terceirizacao de Tecnologia e Servicos SA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competito …
  • Investimentos, Participacoes e Gestao SA (INA):企業の財務・戦略的SWOT分析
    Investimentos, Participacoes e Gestao SA (INA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key str …
  • Safe Orthopaedics SA (SAFOR):企業の製品パイプライン分析2018
    Summary Safe Orthopaedics SA (Safe Orthopaedics) is medical device company that manufactures and markets devices for spinal surgery. The company’s products comprise implants and surgical instruments. It offers modular cervical cages, percutaneous auto-correction screws, modular anchorage screws, per …
  • Cypress Semiconductor Corporation (CY):企業の財務・戦略的SWOT分析
    Cypress Semiconductor Corporation (CY) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths a …
  • Medifocus Inc (MFS):製薬・医療:M&Aディール及び事業提携情報
    Summary Medifocus Inc (Medifocus) is a medical technology company. The company develops and commercializes minimally invasive focused heat systems for the treatment of cancerous and benign tumors, and enlarged prostate. Its technology platforms includes endo-thermotherapy platform, a catheter-based …
  • Theraclone Sciences Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Theraclone Sciences Inc (Theraclone) is a biotech company that develops novel therapeutic antibodies for the treatment of cancer and infectious diseases. The company offers development programs on infectious disease which include novel antibodies to fight pandemic and seasonal influenza. It …
  • ALS Limited (ALQ)-石油・ガス分野:企業M&A・提携分析
    Summary ALS Limited (ALS), formerly, Campbell Brothers Limited is a diversified testing service provider. The company provides testing services in the areas of minerals, life sciences, energy and industrial. It provides chemical and laboratory services, technical testing and inspection services supp …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆